Skip to main content
Erschienen in: Pathology & Oncology Research 1/2010

01.03.2010

The Role of VE-cadherin in Osteosarcoma Cells

verfasst von: Li-Zhi Zhang, Jiong Mei, Zhi-Kang Qian, Xuan-Song Cai, Yao Jiang, Wei-Da Huang

Erschienen in: Pathology & Oncology Research | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Osteosarcoma cells can generate vasculogenic-like, patterned networks to obtain nutrients and oxygen, which mimic some function of endotheial-like cells and facilitate tumor malignant progress. These cells also express vascular endothelial-cadherin (VE-cadherin), which is generally accepted as a strictly endothelial-specific transmembrane protein. However, its role is still relatively obscure in osteosarcoma cells. So we inhibit the VE-cadherin gene expression with siRNA in osteosarcoma cells (MG63), and culture those cells in three-dimensional medium, containing Type I collagen or Matrigel, to observe the role of VE-cadherin. Western blotting analysis show that sequence-specific siRNA can significantly decrease the expression of VE-cadherin in MG63 cell. After knockdown of VE-cadherin, osteosacoma cells cann’t induced angiogenic sprout and form osteosarcoma-generated, endotheial-like networks. Our data indicate that VE-cadherin may be a positive and specific regulator not only in angiogenesis, but also in vasculogenic mimicry of osteosarcoma cells. And it can be considered as a new prospective option in the combining treatment of aggressive tumor with highly vascularity, including osteosarcoma.
Literatur
1.
Zurück zum Zitat Maniotis AJ, Folberg R, Hess A et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739–752PubMed Maniotis AJ, Folberg R, Hess A et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739–752PubMed
2.
Zurück zum Zitat Lissitzky JC, Parriaux D, Ristorcelli E et al (2009) Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Cancer Res 69:802–809CrossRefPubMed Lissitzky JC, Parriaux D, Ristorcelli E et al (2009) Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Cancer Res 69:802–809CrossRefPubMed
3.
Zurück zum Zitat Stevens AP, Spangler B, Wallner S et al (2009) Direct and tumor microenvironment mediated influences of 5′-deoxy-5′-(methylthio) adenosine on tumor progression of malignant melanoma. J Cell Biochem 106:210–219CrossRefPubMed Stevens AP, Spangler B, Wallner S et al (2009) Direct and tumor microenvironment mediated influences of 5′-deoxy-5′-(methylthio) adenosine on tumor progression of malignant melanoma. J Cell Biochem 106:210–219CrossRefPubMed
4.
Zurück zum Zitat Su F, Li B, Wang J (2009) Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2). Graefes Arch Clin Exp Ophthalmol 247:411–419CrossRefPubMed Su F, Li B, Wang J (2009) Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2). Graefes Arch Clin Exp Ophthalmol 247:411–419CrossRefPubMed
5.
Zurück zum Zitat Hendrix MJ, Seftor EA, Meltzer PS (2001) Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A 98:8018–8023CrossRefPubMed Hendrix MJ, Seftor EA, Meltzer PS (2001) Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A 98:8018–8023CrossRefPubMed
7.
Zurück zum Zitat Vestweber D, Winderlich M, Cagna G et al (2009) Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 19:8–15CrossRefPubMed Vestweber D, Winderlich M, Cagna G et al (2009) Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 19:8–15CrossRefPubMed
8.
Zurück zum Zitat Vestweber D (2008) VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28:223–232CrossRefPubMed Vestweber D (2008) VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28:223–232CrossRefPubMed
9.
Zurück zum Zitat Döme B, Hendrix MJ, Paku S (2007) Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol 170:1–15CrossRefPubMed Döme B, Hendrix MJ, Paku S (2007) Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol 170:1–15CrossRefPubMed
10.
Zurück zum Zitat Monzani E, La Porta CA (2008) Targeting cancer stem cells to modulate alternative vascularization mechanisms. Stem Cell Rev 4:51–56CrossRefPubMed Monzani E, La Porta CA (2008) Targeting cancer stem cells to modulate alternative vascularization mechanisms. Stem Cell Rev 4:51–56CrossRefPubMed
11.
Zurück zum Zitat Shen R, Ye Y, Chen L, Yan Q (2008) Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 3:e1652CrossRefPubMed Shen R, Ye Y, Chen L, Yan Q (2008) Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 3:e1652CrossRefPubMed
12.
Zurück zum Zitat Nikolova-Krstevski V, Bhasin M, Otu HH (2008) Gene expression analysis of embryonic stem cells expressing VE-cadherin (CD144)during endothelial differentiation. BMC Genomics 9:240CrossRefPubMed Nikolova-Krstevski V, Bhasin M, Otu HH (2008) Gene expression analysis of embryonic stem cells expressing VE-cadherin (CD144)during endothelial differentiation. BMC Genomics 9:240CrossRefPubMed
13.
Zurück zum Zitat Dejana E, Orsenigo F, Lampugnani MG (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115–2122CrossRefPubMed Dejana E, Orsenigo F, Lampugnani MG (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115–2122CrossRefPubMed
14.
Zurück zum Zitat Wallez Y, Vilgrain I, Huber P (2006) Angiogenesis: the VE-cadherin switch. Trends Cardiovasc Med 16:55–59CrossRefPubMed Wallez Y, Vilgrain I, Huber P (2006) Angiogenesis: the VE-cadherin switch. Trends Cardiovasc Med 16:55–59CrossRefPubMed
15.
Zurück zum Zitat Taddei A, Giampietro C, Conti A et al (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923–934CrossRefPubMed Taddei A, Giampietro C, Conti A et al (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923–934CrossRefPubMed
16.
Zurück zum Zitat Taveau JC, Dubois M, Le Bihan O et al (2008) Structure of artificial and natural VE-cadherin-based adherens junctions. Biochem Soc Trans 36:189–193CrossRefPubMed Taveau JC, Dubois M, Le Bihan O et al (2008) Structure of artificial and natural VE-cadherin-based adherens junctions. Biochem Soc Trans 36:189–193CrossRefPubMed
17.
Zurück zum Zitat Boda-Heggemann J, Régnier-Vigouroux A, Franke WW (2009) Beyond vessels: occurrence and regional clustering of vascular endothelial(VE-)cadherin-containing junctions in non-endothelial cells. Cell Tissue Res 335:49–65CrossRefPubMed Boda-Heggemann J, Régnier-Vigouroux A, Franke WW (2009) Beyond vessels: occurrence and regional clustering of vascular endothelial(VE-)cadherin-containing junctions in non-endothelial cells. Cell Tissue Res 335:49–65CrossRefPubMed
18.
Zurück zum Zitat Hess AR, Seftor EA, Gruman LM et al (2006) VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 5:228–233PubMedCrossRef Hess AR, Seftor EA, Gruman LM et al (2006) VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 5:228–233PubMedCrossRef
19.
Zurück zum Zitat Pezzolo A, Parodi F, Corrias MV et al (2007) Tumor origin of endothelial cells in human neuroblastoma. J Clin Oncol 25:376–383CrossRefPubMed Pezzolo A, Parodi F, Corrias MV et al (2007) Tumor origin of endothelial cells in human neuroblastoma. J Clin Oncol 25:376–383CrossRefPubMed
Metadaten
Titel
The Role of VE-cadherin in Osteosarcoma Cells
verfasst von
Li-Zhi Zhang
Jiong Mei
Zhi-Kang Qian
Xuan-Song Cai
Yao Jiang
Wei-Da Huang
Publikationsdatum
01.03.2010
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 1/2010
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-009-9198-1

Weitere Artikel der Ausgabe 1/2010

Pathology & Oncology Research 1/2010 Zur Ausgabe

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.